Evofem Biosciences Inc (OTCQB:EVFM)
| 0.07 Delayed Data As of Dec 07 |  0.00 / 0.00%Today’s Change | 0.06 Today|||52-Week Range 10.63 | -99.12% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -43.2M | -13.0M | -10.0M | -125.7M | |
| Depreciation | 58.4K | 69.1K | 45.9K | 262.0K | ||
| Total Other Cash Flow | 1.8M | 1.2M | 815.7K | 65.9M | ||
| Funds From Operations | -41.3M | -11.8M | -9.1M | -59.6M | ||
| Funds From/For Other Operating Expenses | -3.4M | 4.5M | -930.9K | -3.1M | ||
| Net Cash Flow - Operating Activities | -37.9M | -16.3M | -8.2M | -56.5M | ||
| Investing | Increase In Investments | -200.0K | 0.00 | 0.00 | 0.00 | |
| Capital Expenditures | -226.1K | 0.00 | 0.00 | -7.0K | ||
| Fixed Asset Disposal | 0.00 | 3.1K | 7.1K | 2.2M | ||
| Net Cash Flow Investing | -426.1K | 3.1K | 7.1K | 2.1M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | -10.1M | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 138.6K | 33.5K | 26.3K | 56.2M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -157.0K | ||
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 1.6M | ||
| Net Cash Flow - Financing | 138.6K | -10.0M | 26.4K | 54.4M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -38.2M | -26.3M | -8.2M | 60.0K | ||
